Full Press Release Details
Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX s property
and may be made public.
Introduced 30/09/01 Amended 01/01/11
| IName of entity Kazia Therapeutics Limited ( Kazia ) |
| rsN 37 063 259 754 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr lain Ross | |
| Date of last notice | 21 December 2021 |
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a
director should be disclosed in this part.
| Direct or indirect interest | Direct | |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | ||
| Date of change | 6 September 2022 | |
| No. of securities held prior to change | 1,075,001 ordinary shares 400,000 unlisted options | |
| Class | Ordinary shares | |
| Number acquired | 175,000 | |
| Number disposed | N/A |
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Change of Director s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | 175,000 ordinary shares at $0.2207 per share | |
| No. of securities held after change | 1,250,001 ordinary shares 400,000 unlisted options | |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Purchased on market |
Part 2 - Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be
disclosed in this part.
| Detail of contract | ||
| Nature of interest | ||
| Name of registered holder (if issued securities) | ||
| Date of change | ||
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
See chapter 19 for defined terms.
Change of Director s Interest Notice
| Interest acquired | ||
| Interest disposed | ||
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | ||
| Interest after change |
Part 3 - +closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No | |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A | |
| If prior written clearance was provided, on what date was this provided? |
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Change of Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become
ASX s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| IName of entity Kazia Therapeutics Limited ( Kazia ) |
| rsN 37 063 259 754 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
| Name of Director | Steven Coffey | |
| Date of last notice | 21 December 2021 |
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a
director should be disclosed in this part.
| Direct or indirect interest | Indirect | |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Fortune 501 Pty Limited (SR Coffey Superfund) Steven Coffey Coffey Family Investments Pty Limited | |
| Date of change | 6 & 7 September 2022 | |
| No. of securities held prior to change | 426,250 ordinary shares (indirect) 8,015 ordinary shares (direct) 400,000 unlisted options (direct) 50,000 ordinary shares | |
| Class | Ordinary shares | |
| Number acquired | 50,000 ordinary shares (indirect) | |
| Number disposed |
See chapter 19 for defined terms.
01/01/20n Appendix 3Y Page 1
Change of Director s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | 73,372 ordinary shares at $0.2097 per share 26,628 ordinary shares at $0.235 per share | |
| No. of securities held after change | 426,250 ordinary shares (indirect) 8,015 ordinary shares (direct) 400,000 unlisted options (direct) 100,000 ordinary shares (indirect) | |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Purchased on market |
Part 2 - Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be
disclosed in this part.
| Detail of contract | ||
| Nature of interest | ||
| Name of registered holder (if issued securities) | ||
| Date of change | ||
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
See chapter 19 for defined terms.
Change of Director s Interest Notice
| Interest acquired | ||
| Interest disposed | ||
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | ||
| Interest after change |
Part 3 - +closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No | |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A | |
| If prior written clearance was provided, on what date was this provided? |
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Change of Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become
ASX s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| IName of entity Kazia Therapeutics Limited ( Kazia ) |
| rsN 37 063 259 754 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr James Garner | |
| Date of last notice | 21 December 2021 |
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a
director should be disclosed in this part.
| Direct or indirect interest | Direct | |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | ||
| Date of change | 6 & 7 September 2022 | |
| No. of securities held prior to change | 500,000 ordinary shares 4,500,000 unlisted options | |
| Class | Ordinary shares | |
| Number acquired | 100,000 ordinary shares | |
| Number disposed | N/A |
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Change of Director s Interest Notice
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | 50,000 ordinary shares at an average price of $0.2250 50,000 ordinary shares at an average price of $0.2377 | |
| No. of securities held after change | 600,000 ordinary shares 4,500,000 unlisted options | |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Purchased on market |
Part 2 - Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be
disclosed in this part.
| Detail of contract | ||
| Nature of interest | ||
| Name of registered holder (if issued securities) | ||
| Date of change |
See chapter 19 for defined terms.
Change of Director s Interest Notice
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | ||
| Interest acquired | ||
| Interest disposed | ||
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | ||
| Interest after change |
Part 3 - +closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No | |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A | |
| If prior written clearance was provided, on what date was this provided? |
See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Change of Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become
ASX s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
| IName of entity Kazia Therapeutics Limited ( Kazia ) |
| rsN 37 063 259 754 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Bryce Carmine | |
| Date of last notice | 21 December 2021 |
Part 1 - Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a
director should be disclosed in this part.